Purpose Investments Inc. Launches Europe’s First Cannabis ETF in Partnership with HANetf

Published: January 15, 2020

Purpose Investments Inc. Launches Europe’s First Cannabis ETF in Partnership with HANetf

Purpose Investments Inc. (“Purpose”) is thrilled today to launch the Medical Cannabis & Wellness UCITS ETF (“the Fund”), representing Purpose’s first offering in the European market. The Fund is being made available through Purpose’s partnership with HANetf, an independent European ETF specialist backed by renowned investor Steve Cohen’s Point72 Ventures.

The first of its kind for European investors, the Fund listed earlier today on the Deutsche Boerse XETRA exchange in Germany. It will be listed on the London Stock Exchange in the UK and the Borsa Italiana in Italy later this month.

“The medical cannabis industry was pioneered in Canada, and we’re thrilled with the opportunity to partner with HANetf to take what we have learned from our Purpose Marijuana Opportunities Fund (MJJ) to Europe. We believe that the cannabis sector is still in the infancy stages of a multi-year growth phase and that there is ample opportunity for innovation and new discoveries. We are very excited to embark on this journey with HANetf in a global investor market,” said Som Seif, CEO and founder of Purpose Investments.

The Fund offers European investors unique exposure to the global medical cannabis market and the CBD wellness sector. Additionally, the Fund invests in ancillary services that support companies within the medical cannabis and CBD categories.

“Up until now, European investors have experienced restricted access to the cannabis market. With the launch of this truly innovative ETF, there is now a product for investors who want exposure to the cannabis industry through a pre-screened basket of Cannabis securities and in a regulated UCITS ETF,” said Hector McNeil, co-Founder and co-CEO of HANetf. “Due to the operational and legal due diligence that has gone into developing this truly innovative ETF, investors can readily access an investment vehicle which can significantly reduce their legal risk versus investing directly in single cannabis securities. It is also is a great way to diversify as investors don’t need to research each individual security and the ETF may help to withstand the short-term volatility of individual securities, potentially making for a lower risk, longer-term investment.”

For more information on the Fund, please visit https://www.hanetf.com/product/6/fund/the-medical-cannabis-and-wellness-ucits-etf-acc

Recent News

View All News Items

Latest Article

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).

 

Read Article